Success Stories

Can-Fite BioPharma

Novel treatments for auto-immune diseases and cancer

Can-Fite BioPharma (TASE:CFBI; NYSE MKT:CANF) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company has an advanced pipeline of proprietary compounds in phase 2 and 3 clinical development stage, which address autoimmune-inflammatory and cancer diseases.

Can-Fite BioPharma
Share this Page:
Font Resize